Ceglia, Nicholas
Sethna, Zachary
Freeman, Samuel S.
Uhlitz, Florian
Bojilova, Viktoria
Rusk, Nicole http://orcid.org/0000-0003-2663-6288
Burman, Bharat
Chow, Andrew http://orcid.org/0000-0003-1151-2450
Salehi, Sohrab
Kabeer, Farhia
Aparicio, Samuel
Greenbaum, Benjamin D. http://orcid.org/0000-0001-6153-8793
Shah, Sohrab P. http://orcid.org/0000-0001-6402-523X
McPherson, Andrew
Article History
Received: 8 July 2022
Accepted: 4 July 2023
First Online: 20 July 2023
Competing interests
: B.D.G. has received honoraria for speaking engagements from Merck, Bristol-Meyers Squibb and Chugai Pharmaceuticals; has received research funding from Bristol-Meyers Squibb; and has been a compensated consultant for PMV Pharma and Rome Therapeutics of which he is a co-founder. S.P.S. reports personal fees from Imagia Canexia Inc. S.S.F. is a co-inventor on provisional patent application No.62/866,261 titled “Methods for predicting outcomes of checkpoint inhibition and treatment thereof” related to prediction of melanoma immunotherapy outcomes. The remaining authors declare no competing interests.